Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 result for epoprostenol

  1. Sotatercept for treating pulmonary arterial hypertension (TA1161)

    Evidence-based recommendations on sotatercept (Winrevair) for pulmonary arterial hypertension in adults.

    Technology appraisal guidance
    Published
    3 June 2026
    View recommendations

    Sections for TA1161